Close
The page header's logo
Help
Login
Staff Login
Register
0
Selected 
Invert selection
Deselect all
Deselect all
 Add to Cart
 Click here to refresh results
 Click here to refresh results
Go to Login page
 Hide details
doctype icon
Conceptually similar
3rd major COVID-19 vaccine shown to be effective
play button
CP112067360 | 3rd major COVID-19 vaccine shown to be effective 
Trump: Vaccine trials on track to combat pandemic
play button
CP21197135 | Trump: Vaccine trials on track to combat pandemic 
What to know about Johnson & Johnson's COVID-19 vaccine
play button
CP119565630 | What to know about Johnson & Johnson's COVID-19 vaccine 
Mich. participants helped vaccine trial diversity
play button
CP111826816 | Mich. participants helped vaccine trial diversity 
Phase III trial of Cuban COVID vaccine to begin
play button
CP118912860 | Phase III trial of Cuban COVID vaccine to begin 
California vaccine recipients react to JandJ pause
play button
CP121600771 | California vaccine recipients react to JandJ pause 
COVID vaccine expands to elementary-age kids
play button
CP139945721 | COVID vaccine expands to elementary-age kids 
Pfizer production issues delaying vaccine deliveries to Canada
play button
CP115243262 | Pfizer production issues delaying vaccine deliveries to Canada 
Canadian-made Ebola vaccine to start clinical trials
play button
CP14666664 | Canadian-made Ebola vaccine to start clinical trials 
Vaccination plans for Canadians on the rise
play button
CP111852171 | Vaccination plans for Canadians on the rise 
Action button

Trial participants react to news on COVID vaccine

Three participants in the AstraZeneca clinical trial for the COVID-19 vaccine say news that the vaccine produced by Pfizer Inc. may be 90% effective is encouraging and they are all a team, no matter who finishes first. (Nov. 10) 
Actions
 Add to collection
 Add to cart
Information
Source name: 
The Associated Press
Unique identifier: CP111599521 
Legacy Identifier: fd272c4f736649edb344f1bad53aab18 
Type: Video 
Duration: 50s 
Dimensions: 1920px × 1080px     62.19 MB 
Usage rights: Digital platform use only. Broadcast rights and editing of content prohibited. 
Create Date: 11/10/2020 2:57:39 PM 
Display aspect ratio: 16:9